CHRONIC INDUCIBLE URTICARIA
Clinical trials for CHRONIC INDUCIBLE URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC INDUCIBLE URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC INDUCIBLE URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill could tame stubborn hives when antihistamines fail
Disease control Recruiting nowThis study tests an experimental drug called BLU-808 for people with chronic hives (either triggered by heat/cold/pressure or happening without a clear cause) that don't get better with standard allergy pills. The drug works by blocking a protein called KIT, which may calm the im…
Matched conditions: CHRONIC INDUCIBLE URTICARIA
Phase: PHASE2 • Sponsor: Blueprint Medicines Corporation • Aim: Disease control
Last updated May 26, 2026 04:45 UTC
-
New hope for cold hives and scratch-induced welts: phase 3 drug trial underway
Disease control Recruiting nowThis study tests an investigational drug called barzolvolimab in 240 adults who still get hives from cold temperatures or skin scratching despite taking antihistamines. Participants receive either the drug or a placebo to see if it can stop these reactions. The goal is to find a …
Matched conditions: CHRONIC INDUCIBLE URTICARIA
Phase: PHASE3 • Sponsor: Celldex Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:45 UTC
-
New shot aims to calm stubborn hives triggered by cold or scratching
Symptom relief Recruiting nowThis early-stage study tests a single dose of a new drug called GTX-B001 in healthy volunteers and people with chronic inducible urticaria — a condition where cold or scratching causes painful hives. The main goal is to check safety and side effects. About 72 people will take par…
Matched conditions: CHRONIC INDUCIBLE URTICARIA
Phase: PHASE1 • Sponsor: Granular Therapeutics Limited • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
New pill for chronic hives takes first step in human testing
Knowledge-focused Recruiting nowThis early-stage study tests an experimental oral drug called EDP-978 in 98 healthy adults. The main goal is to check safety and how the drug moves through the body. It is the first time this drug is given to humans, and results will guide future studies for people with chronic h…
Matched conditions: CHRONIC INDUCIBLE URTICARIA
Phase: PHASE1 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Knowledge-focused
Last updated May 26, 2026 04:46 UTC